NASDAQ:NH - Nasdaq - US6301043054 - Common Stock - Currency: USD
1.35
-1.18 (-46.64%)
The current stock price of NH is 1.35 USD. In the past month the price decreased by -10.6%. In the past year, price decreased by -82.91%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.05 | 38.77B | ||
DOCS | DOXIMITY INC-CLASS A | 46.42 | 11.15B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.14B | ||
CERT | CERTARA INC | 28.4 | 2.06B | ||
SDGR | SCHRODINGER INC | N/A | 1.85B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 14.39 | 1.71B | ||
PHR | PHREESIA INC | N/A | 1.50B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.26B | ||
EVH | EVOLENT HEALTH INC - A | 15.97 | 1.24B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
HSTM | HEALTHSTREAM INC | 50.8 | 1.02B | ||
CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 779.53M |
NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. The company is headquartered in Morrisville, North Carolina and currently employs 364 full-time employees. The company went IPO on 2016-06-02. The firm is engaged in offering ways to move, interpret, and visualize complex and highly sensitive information to its customers in the healthcare, life sciences, logistics, telecommunications, and other industries to automate, understand, and act on data while keeping it secure and scalable. The Company’s products include Eviti Connect and Eviti Advisor, NaviNet, NaviNet Open, NaviNet AllPayer, OpenNMS, and Quadris. Its product portfolio comprises the technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet) and data solutions that include multi-data analysis, reporting, and professional service offerings (Quadris). In addition, The OpenNMS Group, Inc. (OpenNMS), a Company’s subsidiary, helps businesses monitor and manage network health and performance.
NANTHEALTH INC
3000 Rdu Center Drive, Suite 200
Morrisville NORTH CAROLINA 90232 US
CEO: Patrick Soon-Shiong
Employees: 364
Phone: 18559496288.0
The current stock price of NH is 1.35 USD. The price decreased by -46.64% in the last trading session.
The exchange symbol of NANTHEALTH INC is NH and it is listed on the Nasdaq exchange.
NH stock is listed on the Nasdaq exchange.
9 analysts have analysed NH and the average price target is 61.2 USD. This implies a price increase of 4433.33% is expected in the next year compared to the current price of 1.35. Check the NANTHEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
NANTHEALTH INC (NH) has a market capitalization of 10.40M USD. This makes NH a Nano Cap stock.
NANTHEALTH INC (NH) currently has 364 employees.
NANTHEALTH INC (NH) has a resistance level at 2.7. Check the full technical report for a detailed analysis of NH support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NH does not pay a dividend.
NANTHEALTH INC (NH) will report earnings on 2023-08-02.
NANTHEALTH INC (NH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-8.32).
ChartMill assigns a technical rating of 1 / 10 to NH. When comparing the yearly performance of all stocks, NH is a bad performer in the overall market: 96.89% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to NH. NH may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months NH reported a non-GAAP Earnings per Share(EPS) of -8.32. The EPS decreased by -240.38% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 84% to NH. The Buy consensus is the average rating of analysts ratings from 9 analysts.